Murine CR1/2 targeted antigenized single-chain antibody fragments induce transient low affinity antibodies and negatively influence an ongoing immune response

Advances in Experimental Medicine and Biology

Volumn 598, Issue , 2007, Pages 214-225

  Prechl, József ^a   Molnár, Eszter ^a   Szekeres, Zsuzsanna ^a   Isaák, Andrea ^a   Papp, Krisztián ^a   Balogh, Péter ^b   Erdei, Anna ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR CR2; EPITOPE; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIGEN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; CROSS LINKING; DRUG TARGETING; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFLUENZA; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE;

MURINAE;

EID: 84934443465     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-71767-8_15     Document Type: Conference Paper

References (21)

1. Ahearn, J.M., Fischer, M.B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X., Howard, R.G., Rothstein, T.L., Carroll, M.C., 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4, 251-262.
2. Applequist, S.E., Dahlstrom, J., Jiang, N., Molina, H., Heyman, B., 2000. Antibody production in mice deficient for complement receptors 1 and 2 can be induced by IgG/Ag and IgE/Ag, but not IgM/Ag complexes. J. Immunol. 165, 2398-2403.
3. Baiu, D.C., Prechl, J., Tchorbanov, A., Molina, H.D., Erdei, A., Sulica, A., Capel, P.J., Hazenbos, W.L., 1999. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J. Immunol. 162, 3125-3130.
4. Chen, Z., Koralov, S.B., Gendelman, M., Carroll, M.C., Kelsoe, G., 2000. Humoral immune responses in Cr2-/- mice: enhanced affinity maturation but impaired antibody persistence. J. Immunol. 164, 4522-4532.
5. Croix, D.A., Ahearn, J.M., Rosengard, A.M., Han, S., Kelsoe, G., Ma, M., Carroll, M.C., 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183, 1857-1864.
6. Dempsey, P.W., Allison, M.E., Akkaraju, S., Goodnow, C.C., Fearon, D.T., 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science %19;271, 348-350.
7. Fearon, D.T., Carroll, M.C., 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18, 393-422.
8. Gaither, T.A., Vargas, I., Inada, S., Frank, M.M., 1987. The complement fragment C3d facilitates phagocytosis by monocytes. Immunology 62, 405-411.
9. Haas, K.M., Hasegawa, M., Steeber, D.A., Poe, J.C., Zabel, M.D., Bock, C.B., Karp, D.R., Briles, D.E., Weis, J.H., Tedder, T.F., 2002. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity. 17, 713-723.
10. Haas, K.M., Toapanta, F.R., Oliver, J.A., Poe, J.C., Weis, J.H., Karp, D.R., Bower, J.F., Ross, T.M., Tedder, T.F., 2004. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J. Immunol. 172, 5833-5837.
11. Lou, D., Kohler, H., 1998. Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide. Nat. Biotechnol. 16, 458-462.
12. Molina, H., Holers, V.M., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J., Karr, R.W., Chaplin, D.D., 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U. S. A 93, 3357-3361.
13. Prechl, J., Tchorbanov, A., Horvath, A., Baiu, D.C., Hazenbos, W., Rajnavolgyi, E., Kurucz, I., Capel, P.J., Erdei, A., 1999. Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies. Immunopharmacology 42, 159-165.
14. Qin, D., Wu, J., Carroll, M.C., Burton, G.F., Szakal, A.K., Tew, J.G., 1998. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J. Immunol. 161, 4549-4554.
15. Rajnavolgyi, E., Horvath, A., Gogolak, P., Toth, G.K., Fazekas, G., Fridkin, M., Pecht, I., 1997. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Eur. J. Immunol. 27, 3105-3114.
16. Ross, T.M., Xu, Y., Bright, R.A., Robinson, H.L., 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1, 127-131.
17. Ross, T.M., Xu, Y., Green, T.D., Montefiori, D.C., Robinson, H.L., 2001. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res. Hum. Retroviruses 17, 829-835.
18. Villiers, M.B., Villiers, C.L., Laharie, A.M., Marche, P.N., 1999. Amplification of the antibody response by C3b complexed to antigen through an ester link. J. Immunol. 162, 3647-3652.
19. Whipple, E.C., Shanahan, R.S., Ditto, A.H., Taylor, R.P., Lindorfer, M.A., 2004. Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice. J. Immunol. 173, 2297-2306.
20. Wu, X., Jiang, N., Fang, Y.F., Xu, C., Mao, D., Singh, J., Fu, Y.X., Molina, H., 2000. Impaired affinity maturation in Cr2-/- mice is rescued by adjuvants without improvement in germinal center development. J. Immunol. 165, 3119-3127.
21. Wykes, M., Pombo, A., Jenkins, C., MacPherson, G.G., 1998. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161, 1313-1319.